NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Decline Continues Amid Fears of Escalation in West Asia War and Looming Deadline for US-Iran Deal

The benchmark equity indices Sensex and Nifty declined on Tuesday, weighed down by fears of escalation in the West Asia war and a looming deadline set by U.S. President Donald Trump for a deal. At around 10:30 am, the Sensex was down 104.45 points or 0.14 percent at 74,002.41, while the broader Nifty was at 22,939.60, down 28.65 points or 0.12 percent.

Key Factors Behind Market Decline

Several key factors contributed to the market decline on Tuesday. The escalation of tensions in the West Asia war was a major concern, with U.S. President Donald Trump reiterating threats to strike Iran's power plants and civilian infrastructure unless Tehran reaches a deal by 5:30 a.m. IST on Wednesday, to reopen the Strait of Hormuz. Iran has responded by stating that it wants a permanent end to the conflict, rather than a temporary ceasefire.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Another factor weighing on the market was the rise in crude oil prices. Brent crude hovered around $112 per barrel, putting pressure on India's import bill and economic growth. Elevated crude prices also strain corporate margins, making it challenging for companies to maintain profitability.

The persistent selling of equities by Foreign Institutional Investors (FIIs) was another contributing factor to the market decline. On Monday, FIIs sold equities worth Rs 8,167.17 crore.

IndicatorValueChange
Sensex74,002.41Down 104.45 points (0.14%)
Nifty22,939.60Down 28.65 points (0.12%)
Brent Crude$112 per barrelN/A
FII SellingRs 8,167.17 croreN/A

Investor Takeaway

Investors should be cautious and monitor global events that may impact the market.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.